We are live on ! Find out more
RLYB icon

Rallybio
RLYB

57 hedge funds and large institutions have $212M invested in Rallybio in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 10

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

8% more funds holding

Funds holding: 53 → 57 (+4)

0.09% more ownership

Funds ownership: 10.81% → 10.91% (+0.09%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

47% less capital invested

Capital invested by funds: $402M → $212M (-$190M)

Holders
57
Holders Change
+4
Holders Change %
+7.55%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
10
Increased
27
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
+$12.3M
2
NLVP
New Leaf Venture Partners
New York
+$7.38M
3
CA
CHI Advisors
New York
+$3.92M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$2.85M
5
LCM
Laurion Capital Management
New York
+$2.81M

Top Sellers

Rank Fund Capital Flow
1
CPX
Canaan Partners XI
California
-$2.58M
2
BlackRock
BlackRock
New York
-$271K
3
AA
ALPS Advisors
Colorado
-$254K
4
TCM
Tekla Capital Management
Massachusetts
-$102K
5
Goldman Sachs
Goldman Sachs
New York
-$93.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$27.6M – – –
5VM
2
5AM Venture Management
California
$24.5M – – –
NLVP
3
New Leaf Venture Partners
New York
$21.7M +$7.38M +125,000 +43%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$21.3M +$2.59M +43,947 +12%
TGA
5
TPG GP A
Texas
$19.9M – – –
PBPIA
6
Pivotal bioVenture Partners Investment Advisor
California
$15.8M +$984K +16,667 +6%
NHAS
7
Novo Holdings A/S
Denmark
$15.1M +$12.3M +208,136 +264%
CPX
8
Canaan Partners XI
California
$13.5M -$2.58M -43,750 -15%
TCM
9
Tekla Capital Management
Massachusetts
$11.3M -$102K -1,733 -0.8%
Vanguard Group
10
Vanguard Group
Pennsylvania
$6.36M +$1.25M +21,258 +21%
BlackRock
11
BlackRock
New York
$6.23M -$271K -4,584 -4%
LCM
12
Laurion Capital Management
New York
$5.15M +$2.81M +47,661 +95%
CA
13
CHI Advisors
New York
$4.77M +$3.92M +66,477 +274%
SAM
14
Sectoral Asset Management
Quebec, Canada
$4.07M +$2.85M +48,313 +166%
Citadel Advisors
15
Citadel Advisors
Florida
$2.32M +$2.61M +44,172 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.96M +$276K +4,670 +14%
State Street
17
State Street
Massachusetts
$1.77M +$127K +2,153 +7%
VA
18
VR Adviser
New York
$1.76M – – –
CCM
19
CAAS Capital Management
New York
$1.72M +$1.93M +32,718 New
Vontobel Holding
20
Vontobel Holding
Switzerland
$1.16M +$1.3M +21,997 New
Northern Trust
21
Northern Trust
Illinois
$885K +$62.7K +1,063 +7%
Walleye Capital
22
Walleye Capital
New York
$526K +$591K +10,012 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$340K +$74.5K +1,262 +24%
Charles Schwab
24
Charles Schwab
California
$305K +$46K +779 +15%
Bank of America
25
Bank of America
North Carolina
$267K +$279K +4,731 +1,333%
1
2 3

RLYB Hedge Fund Activity: Q4 2022 in Review

57 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q4 2022, worth a combined $212M — down 47% from $402M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new RLYB positions and 5 closed out — a net gain of 5 holders — while 27 added to existing stakes and 10 trimmed.

The largest buyer was Novo Holdings A/S, adding an estimated $12.3M. The largest seller was Canaan Partners XI, cutting an estimated $2.58M.

  • 57 institutional investors held Rallybio (RLYB) as of Q4 2022, up from 53 in Q3 2022.
  • Funds reported $212M of Rallybio stock for Q4 2022, down 47% quarter-over-quarter.
  • 10 funds opened new Rallybio positions in Q4 2022 and 5 closed out, a net change of +5 holders.
  • The largest Rallybio buyer in Q4 2022 was Novo Holdings A/S, an estimated $12.3M added.
  • The largest Rallybio seller in Q4 2022 was Canaan Partners XI, an estimated $2.58M sold.

Based on aggregated 13F filings for Q4 2022.